Stock 0P3C KAROLINSKA DEVELOPMENT AB
Add to a list
To use this feature you must be a member
Log inSign up

Company Karolinska Development AB London S.E.

Equities

0P3C

SE0002190926

Medical Equipment, Supplies & Distribution

Market Closed - London S.E.
Other stock markets
 10:34:22 2022-09-06 EDT 		5-day change 1st Jan Change
2.403 SEK +48.79% Intraday chart for Karolinska Development AB +55.67% +42.47%
07-10 Umecrine Cognition AB announced that it has received SEK 28.3 million in funding from Ribbskottet AB, AB Ility AB, Karolinska Development AB and other investors CI
05-28 Karolinska Development Targets 10% Stake in Boost Pharma MT

Business Summary

Karolinska Development AB is a Sweden-based investment company. The Company provides capital to biotechnology firms, as well as develops and commercializes biotechnological products. Its activities are involved in a range of areas: oncology, infections and wound healing, women’s health, cardiovascular and hematology, medical equipment, diagnostics, pharmaceutical formulation, as well as implants, among others. The Company’s pharmaceuticals portfolio comprises: AXL1717 for non-small-cell lung carcinoma (NSCLC), APR-246 for ovarian cancer, Sevuparin for malaria, SHACT for pain relief at hysteroscopy and intrauterine device (IUD) insertion, and PC-mAB for acute coronary syndrome (ACS), among others. Furthermore, the Company controls a number of subsidiaries, such as Avaris AB, HBV Thernostica AB, KD Incentive AB, KDev Oncology AB and Limone AB.

Number of employees: 8

Sales per Business

SEK in Million2022Weight2023Weight Delta
Investment and Related Activities
100.0 %
2 100.0 % 2 100.0 % -12.43%

Sales per region

SEK in Million2022Weight2023Weight Delta
Sweden
100.0 %
2 100.0 % 2 100.0 % -12.43%

Managers

Managers TitleAgeSince
Viktor Drvota CEO
 Chief Executive Officer 59 15-12-06
Hans Christopher Toll DFI
 Director of Finance/CFO 56 22-09-30
John Öhd CTO
 Chief Tech/Sci/R&D Officer 53 20-05-31
Per Gunnar Ernst Aniansson CIO
 Chief Investment Officer 58 21-02-28
Linda Spahiu PRN
 Corporate Officer/Principal 39 -
Johan Dighed LAW
 General Counsel 51 20-04-30
Elisabet Gimbringer PRN
 Corporate Officer/Principal 59 15-10-31
Eva Montgomerie AUD
 Comptroller/Controller/Auditor 66 06-12-31
Thomas Andersson PRN
 Corporate Officer/Principal 72 -

Members of the board

Members of the board TitleAgeSince
Viktor Drvota CEO
 Chief Executive Officer 59 15-12-06
Anna Lefevre Skjöldebrand BRD
 Director/Board Member 55 21-02-18
Benjamin Toogood BRD
 Director/Board Member 48 21-02-18
Theresa Tse BRD
 Director/Board Member 32 17-11-27
Philip Duong BRD
 Director/Board Member 34 22-01-11

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 10 2,555,261 0 0 35.19 %
Stock B 1 267,522,333 95,049,884 ( 35.53 %) 244,285 ( 0.0913 %)

Shareholders

NameEquities%Valuation
FCG Fonder AB
0.2497 %
668,074 0.2497 % 90 210 kr
Storebrand Asset Management AS
0.0933 %
249,486 0.0933 % 33 688 kr
Equinor Asset Management ASA
0.0203 %
54,300 0.0203 % 7 332 kr
Skandia Fonder AB
0.0164 %
43,902 0.0164 % 5 928 kr

Holdings

NameEquities%Valuation
OSSDSIGN AB
9.83%
 9,596,662 9.83% 8,427,501 $

Company contact information

Karolinska Development AB

Tomtebodavägen 23 A

171 65, Solna

+46 8 524 860 70

http://www.karolinskadevelopment.com
address Karolinska Development AB(0P3C)

Group companies

NameCategory and Sector
KDev Investments AB
Logo KDev Investments AB

KDev Investments AB

BiotechnologyHealth Technology

KDev Investments AB engages in research, sales, and development in the fields of medicine, biotechnology, pharmaceuticals, and medical technology. It also owns and manages investments of companies in the fields of medicine. Its portfolio will include both early and clinical stage pharmaceutical assets, as well as some technology assets. The company was founded on January 10, 2012 and is headquartered in Solna, Sweden.

Biotechnology

Sector

Healthcare
Healthcare Services
Healthcare Equipment & Supplies
Medical Equipment, Supplies & Distribution
Other Medical Equipment, Supplies & Distribution

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
ABBOTT LABORATORIES Stock Abbott Laboratories
-6.70% 179B
MEDTRONIC PLC Stock Medtronic plc
-5.78% 98.84B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-5.49% 65.34B
HOYA CORPORATION Stock Hoya Corporation
+15.46% 45.41B
DEXCOM, INC. Stock DexCom, Inc.
-7.14% 44.94B
CENCORA, INC. Stock Cencora, Inc.
+9.57% 43.76B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+13.42% 29.01B
TERUMO CORPORATION Stock Terumo Corporation
+19.39% 25.65B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
-6.57% 23.32B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. KDEV Stock
  4. 0P3C Stock
  5. Company Karolinska Development AB